Reality Bites: Disappointment in the R&D Sector
Pharmaceutical Technology
JULY 10, 2008
As the blockbuster drugs of the 90s that earned the industry billions reach their patent shelf lives, pharmaceutical companies require new medicines to sustain an estimated $157bn worth of sales. Even so, current figures show firms’ biggest portion of spend is still on marketing and administration at 33.1%,
52 
Let's personalize your content